4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000040
CEO sold 1,900 shares at an average $17.84 ($33,897)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal CEO | 2024-07-12 | Sale 10b5-1 | −300 | $18.00 | $5,400 | 336,075 | D |
| Doshi Dipal CEO | 2024-07-15 | Sale 10b5-1 | −1,600 | $17.81 | $28,497 | 334,475 | D |
| Open-market sales · 1,900 sh · avg $17.84 · $33,897 | |||||||
Loading xslF345X05/wk-form4_1721162529.xml…